학술논문

Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity
Document Type
article
Source
Cancer Communications, Vol 43, Iss 10, Pp 1178-1182 (2023)
Subject
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Language
English
ISSN
2523-3548